Bio-thera Solutions
Clinical trials sponsored by Bio-thera Solutions, explained in plain language.
-
New drug aims to control rare autoimmune disease attacks
Disease control OngoingThis study tests an experimental drug called BAT4406F in 162 adults with neuromyelitis optica spectrum disorder (NMOSD) who have a specific antibody (AQP4-IgG). The goal is to see if the drug can reduce relapses by targeting certain immune cells. Participants receive either the d…
Phase: PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of two experimental drugs, BAT8008 and BAT1308, in people with advanced solid tumors that have not responded to standard treatments. The goal is to find safe doses and see if the drugs can shrink tumors or slow cancer growth. About 112 participants …
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Promising ovarian cancer drug study pulled before it began
Disease control TerminatedThis study was designed to test a new drug called BAT8006 in people with ovarian cancer that no longer responds to platinum-based chemotherapy. The drug works by targeting a protein on cancer cells to deliver a toxic payload directly. However, the study was withdrawn before any p…
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC
-
New eczema drug shows promise in early trial
Symptom relief OngoingThis study tests a new drug called BAT6026 in adults with moderate to severe atopic dermatitis (eczema) that hasn't improved with standard creams. The goal is to see if the drug is safe and can reduce skin symptoms like redness and itching. About 33 participants will receive diff…
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Symptom relief
Last updated Jun 03, 2026 12:02 UTC